← All trials
NCT04709289
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2020
- Primary completion
- Jan 1, 2020
- Completion date
- Feb 28, 2020
- First posted
- Jan 14, 2021
- Last posted
- Jan 14, 2021
- Enrollment
- 40
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Shanghai Dermatology HospitalLead sponsor
- Shanghai Skin Disease HospitalStudy director
- Shanghai Dermatology HospitalReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.